How Effective Is The Flumist Nasal Spray Vaccine?

FluMist is a nasal spray flu vaccine made from weakened live influenza virus. It is approved for people aged 2 through 49 in the United States. In studies used for its approval, it reduced the chance of catching laboratory-confirmed flu compared with receiving a placebo shot. How well it works in any given season depends heavily on which flu strains are circulating and how well the vaccine strains match them.

For years, public health experts debated how FluMist stacks up against the standard flu shot. The picture changed more than once. FluMist was actually not recommended for several seasons, then brought back. That history matters if you are trying to understand how effective it really is.

How Effective Is The Flumist Nasal Spray Vaccine Compared To The Flu Shot?

The comparison depends on which age group you look at and which season you examine. There is no single number that applies to everyone.

In young children, several studies have suggested the nasal spray performed at least as well as, and sometimes better than, the injected vaccine. This was part of why it was originally favored for kids. In older children and adults, the evidence has been less consistent, and some seasons showed the shot working better.

One important chapter: during the 2013–2014 and 2015–2016 flu seasons, US health officials found the nasal spray performed poorly against certain circulating strains, particularly in older children. That led to a period when the CDC stopped recommending it. After the manufacturer reformulated the vaccine, it was recommended again starting in the 2018–2019 season. This is a real example of how vaccine performance can shift and how recommendations get revised when the data change.

The honest summary is that both vaccines protect against flu, and the best choice depends on your age, health history, and what is available. Some clinicians prefer the nasal spray for young children who fear needles. That preference is reasonable but not universal.

How Does The Nasal Spray Flu Vaccine Work?

FluMist contains live but weakened influenza virus. It is sprayed into each nostril, where it reaches the lining of the nose. That lining is where flu virus typically enters the body first.

Because the vaccine is delivered where the virus naturally starts, it triggers an immune response at that entry point, including antibodies in the nasal passages. It also stimulates a broader immune response. The injected flu shot, by contrast, uses killed virus and is given into muscle, so the immune system responds mainly through the bloodstream rather than at the nose itself.

That difference in how the immune system is engaged is real and well documented. Whether it translates into better protection in practice is where the evidence gets murky. The immune response is not automatically superior just because it happens at the site of infection.

One detail worth knowing: because FluMist contains live weakened virus, it is not recommended for people with severely weakened immune systems, pregnant women, or certain other groups. Those restrictions are based on safety concerns with live vaccines, not on doubts about effectiveness.

Who Can Get The Nasal Spray Flu Vaccine?

FluMist is approved for people aged 2 through 49 who are generally healthy. It is not for everyone in that range, though.

Groups who should not receive it include:

• Children younger than 2 years
• Adults 50 and older
• Pregnant women
• People with weakened immune systems
• Children or teens taking aspirin or medicines containing aspirin
• People with a history of severe allergic reaction to flu vaccine or its ingredients
• People with certain chronic conditions, such as some lung or heart conditions
• Children aged 2 through 4 with asthma or a history of wheezing in the past year

Children who are close contacts of someone with a severely weakened immune system may also need to avoid it, because the weakened virus can be shed from the nose for a short time after vaccination. This is a precaution, not evidence of harm in healthy people.

If you fall outside the eligible group, the injected flu vaccine remains an option. Your clinician can advise on which is appropriate for your situation.

What Does The Evidence Say About Protection In Children?

The strongest case for FluMist has historically been in young children. Several studies found it provided good protection in kids, and in some seasons it outperformed the shot in that age group.

That said, the poor performance seen in the mid-2010s involved older children and specific strains. It was not a uniform failure across all ages or all seasons. This is why blanket statements like “the nasal spray is better” or “the nasal spray doesn’t work” are both inaccurate.

What the evidence supports is this: in young children, the nasal spray has generally performed well and is a reasonable option. In older children and adults, results have varied by season, and the injected vaccine has sometimes been the stronger choice. The differences are real but not dramatic in most seasons.

Does FluMist Protect Against All Flu Strains?

No flu vaccine protects against every strain. FluMist is formulated each year to match the strains experts predict will circulate most. When the match is good, protection is better. When the circulating virus drifts away from the vaccine strains, protection drops.

This is true of the injected vaccine as well. Neither type offers guaranteed protection, and neither prevents every case of flu. What vaccination does is lower your chance of getting sick and, importantly, reduce the risk of serious complications if you do get infected.

One clarification that often gets lost: the flu vaccine does not cause the flu. With FluMist, the weakened virus can cause mild symptoms like a runny nose or sore throat, but it cannot cause a full flu infection in healthy people. The virus is engineered to be too weak to do that.

What Are The Common Side Effects?

Side effects from FluMist are generally mild and short-lived. The most common ones in children include a runny nose, nasal congestion, and a low-grade fever. Adults more often report a sore throat, headache, or tiredness.

These reactions typically resolve within a few days. They reflect the immune system responding to the vaccine, not an infection.

Serious reactions are rare. As with any vaccine, there is a small risk of allergic reaction, which is why people with a known severe allergy to flu vaccine ingredients should not receive it. If you have concerns about a specific ingredient or a prior reaction, talk with a clinician before vaccinating.

The Bottom Line On Effectiveness

FluMist is an effective flu vaccine for many people, especially young children, but its performance has varied by season and age group. It is not clearly superior or inferior to the shot in all cases. The evidence supports using it as one valid option within the recommended age and health criteria.

If you are choosing between the nasal spray and the shot, the decision is best made with your clinician, who can weigh your age, health history, and what is available that season. Both reduce the risk of flu. Neither is perfect.